Post-chemotherapy Symptom Management SMART
Completed · Not applicable
Conditions studied: Cancer
In brief
Survivors of solid tumors (N=451) who completed curative intent chemotherapy for a solid tumor within the past 2 years were interviewed at baseline and stratified as high or low need for symptom management based on comorbidity and depressive symptoms. High need survivors were randomized initially to the 12-week Symptom Management and Survivorship Handbook (SMSH, N=282) or 12-week SMSH Telephone Interpersonal Counseling (TIPC, N=93) added during weeks 1-8. After 4 weeks of the SMSH alone, non-responders on depression were re-randomized to continue with SMSH alone (N=30) or add TIPC (N=31).
Key facts
- Study ID
- NCT03494166
- Run by
- University of Arizona
- People needed
- 498
- Starts
- 2018-07-01
- Expected to finish
- 2022-06-03
- Last updated by the study team
- 2023-10-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Survivors must have a new diagnosis or localized recurrence of solid tumor cancer
- Be finishing curative intent adjuvant chemotherapy or chemoradiation, and do not have any subsequent cancer treatments planned, except for radiation therapy, hormonal therapy or trastuzumab for breast cancer.
- 18 years of age or older
- Have access to a telephone
- Understand English or Spanish
- Are not currently receiving counseling and/or psychotherapy
You may not qualify if…
- Diagnosis of a psychotic disorder in medical record verified by the recruiter
- Nursing home resident
- Bedridden
- Currently receiving counseling and/or psychotherapy.
Where it is running
- Cancer Center at St. Joseph's — Phoenix, Arizona, United States
- University of Arizona — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.